Phase 1 Study of BLB-201 Vaccine in Healthy Young and Older Adults

Clinical trial NCT05281263 · COMPLETED

Trial details

NCT number: NCT05281263
Sponsor: Blue Lake Biotechnology Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Respiratory Syncytial Virus Infections

Start date: 2022-07-20
Primary completion: 2022-12-05
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.